Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:850851.
doi: 10.1155/2013/850851. Epub 2013 Mar 14.

Stronger Correlation between Interleukin 18 and Soluble Fas in Lupus Nephritis Compared with Mild Lupus

Mohammad Reza Hatef  1 , Maryam Sahebari, Zahra Rezaieyazdi, Mohammad Reza Nakhjavani, Mahmoud Mahmoudi
Affiliations

Stronger Correlation between Interleukin 18 and Soluble Fas in Lupus Nephritis Compared with Mild Lupus

Mohammad Reza Hatef et al. ISRN Rheumatol. 2013.

Abstract

Lupus nephritis (LN) is a major cause of morbidity in patients with systemic lupus erythematosus (SLE). Several cytokines and apoptotic markers such as IL-18 and soluble Fas (sFas) have been assumed to play a role in the pathogenesis of LN. Previous studies confirmed that serum concentrations of sFas and IL-18 are increased in SLE. However, only a few studies have suggested a possible correlation between IL-18 and sFas. This study was planned to continue our previous study on the correlation between those markers to evaluate this correlation in LN. Thirty-two patients with only LN and 46 patients without any major organ involvement participated in this study. SLEDAI score (except for scores related to nephritis) was the same in these two groups. In both groups, patients with any other major organ involvement were excluded. We found a significant rise in the serum concentrations of sFas (P = 0.03) and IL-18 (P = 0.02) in patients with proteinuria compared to those without it. This study showed that the correlation between sFas and IL-18 in LN (P < 0.001, r p = 0.5) is significantly stronger than it is in mild SLE (P < 0.001, r p = 0.4) with similar nonrenal SLEDAI score (P = 0.032, z = 1.85). Between these two serum markers, sFas is the only predictor of proteinuria.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Correlation between serum values of sFas and IL-18 in patients with proteinuria (P < 0.001, r p = 0.5).
Figure 2
Figure 2
Correlation between serum values of sFas and IL-18 in patients without proteinuria (P < 0.001, r p = 0.4).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Saxena R, Mahajan T, Mohan C. Lupus nephritis: current update. Arthritis Research & Therapy. 2011;(13, article 240) - PMC - PubMed
    1. Houssiau FA, Vasconcelos C, D’Cruz D, et al. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis & Rheumatism. 2002;46(8):2121–2131. - PubMed
    1. Alecu M, Coman G, Alecu S. Serological levels of apoptotic bodies, sFAS and TNF in lupus erythematosus. Romanian Journal of Internal Medicine. 2000;38:83–88. - PubMed
    1. Gigante A, Gasperini ML, Afeltra A, et al. Cytokines expression in SLE nephritis. European Review for Medical and Pharmacological Sciences. 2011;15(1):15–24. - PubMed
    1. Kahlenberg JM, Thacker SG, Berthier CC, Cohen CD, Kretzler M, Kaplan MJ. Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus. The Journal of Immunology. 2011;187(11):6143–6156. - PMC - PubMed